Search Results - Fürstenau, Moritz

Moritz Fürstenau

Moritz Fürstenau as photographed by Robert Eich before 1889. Moritz Ludwig Carl Ignaz Franz August Fürstenau (born 26 July 1824 and died on 27 March 1889, also in Dresden) was a German flautist and music historian. He left only a few works that gained little significance, but was extremely helpful as a theater historian.

With his former conductor Richard Wagner, he remained on friendly terms, standing by him even after his departure from Dresden. As an early admirer of him, he was in the 1870s with the founding of the Dresden Wagner Society and as early as 1854, he was already involved in the establishment of the Musicians Association, remaining chairman until his death. He also served as a delegate of the General German Musician Association. For his services he was granted the title of professor of music from the king. Provided by Wikipedia
  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Acalabrutinib, venetoclax, and obinutuzumab in relapsed/refractory CLL: final efficacy and ctDNA analysis of the CLL2-BAAG trial by Fürstenau, Moritz (Author) , Giza, Adam (Author) , Weiss, Jonathan (Author) , Kleinert, Fanni (Author) , Robrecht, Sandra (Author) , Franzen, Fabian (Author) , Stumpf, Janina (Author) , Langerbeins, Petra (Author) , Al-Sawaf, Othman (Author) , Simon, Florian (Author) , Fink, Anna-Maria (Author) , Schneider, Christof (Author) , Tausch, Eugen (Author) , Schetelig, Johannes (Author) , Dreger, Peter (Author) , Böttcher, Sebastian (Author) , Fischer, Kirsten (Author) , Kreuzer, Karl-Anton (Author) , Ritgen, Matthias (Author) , Schilhabel, Anke (Author) , Brüggemann, Monika (Author) , Stilgenbauer, Stephan (Author) , Eichhorst, Barbara (Author) , Hallek, Michael (Author) , Cramer, Paula (Author) ,


    Get full text
    Article (Journal) Online Resource
  2. 2

    Final analysis of the CLL2-GIVe trial: obinutuzumab, ibrutinib, and venetoclax for untreated CLL with del(17p)/TP53mut by Huber, Henriette (Author) , Tausch, Eugen (Author) , Schneider, Christof (Author) , Edenhofer, Simone (Author) , Tresckow, Julia von (Author) , Robrecht, Sandra (Author) , Giza, Adam (Author) , Zhang, Can (Author) , Fürstenau, Moritz (Author) , Dreger, Peter (Author) , Ritgen, Matthias (Author) , Illmer, Thomas (Author) , Illert, Anna Lena (Author) , Dürig, Jan (Author) , Böttcher, Sebastian (Author) ,


    Get full text
    Article (Journal) Online Resource
  3. 3

    Obinutuzumab (GA-101), ibrutinib, and venetoclax (GIVe) frontline treatment for high-risk chronic lymphocytic leukemia by Huber, Henriette (Author) , Edenhofer, Simone (Author) , von Tresckow, Julia (Author) , Robrecht, Sandra (Author) , Zhang, Can (Author) , Tausch, Eugen (Author) , Schneider, Christof (Author) , Bloehdorn, Johannes (Author) , Fürstenau, Moritz (Author) , Dreger, Peter (Author) , Ritgen, Matthias (Author) , Illmer, Thomas (Author) , Illert, Anna L. (Author) , Dürig, Jan (Author) , Böttcher, Sebastian (Author) , Niemann, Carsten U. (Author) , Kneba, Michael (Author) , Fink, Anna-Maria (Author) , Fischer, Kirsten (Author) , Döhner, Hartmut (Author) , Hallek, Michael (Author) , Eichhorst, Barbara (Author) , Stilgenbauer, Stephan (Author) ,


    Get full text
    Article (Journal) Online Resource
  4. 4

    Obinutuzumab, acalabrutinib, and venetoclax, after an optional debulking with bendamustine in relapsed or refractory chronic lymphocytic leukaemia (CLL2-BAAG): a multicentre, open-... by Cramer, Paula (Author) , Fürstenau, Moritz (Author) , Robrecht, Sandra (Author) , Giza, Adam (Author) , Zhang, Can (Author) , Fink, Anna-Maria (Author) , Fischer, Kirsten (Author) , Langerbeins, Petra (Author) , Al-Sawaf, Othman (Author) , Tausch, Eugen (Author) , Schneider, Christof (Author) , Schetelig, Johannes (Author) , Dreger, Peter (Author) , Böttcher, Sebastian (Author) , Kreuzer, Karl-Anton (Author) , Schilhabel, Anke (Author) , Ritgen, Matthias (Author) , Brüggemann, Monika (Author) , Kneba, Michael (Author) , Stilgenbauer, Stephan (Author) , Eichhorst, Barbara (Author) , Hallek, Michael (Author) ,


    Get full text
    Article (Journal) Online Resource
  5. 5

    Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease status in chronic lymp... by Fürstenau, Moritz (Author) , Bahlo, J. (Author) , Fink, A. M. (Author) , Lange, E. (Author) , Dreger, Peter (Author) , Dreyling, M. (Author) , Hess, G. (Author) , Ritgen, M. (Author) , Kneba, M. (Author) , Döhner, H. (Author) , Stilgenbauer, S. (Author) , Wendtner, C. M. (Author) , Goede, V. (Author) , Fischer, K. (Author) , Böttcher, S. (Author) , Hallek, M. (Author) , Eichhorst, B. (Author) ,


    Get full text
    Article (Journal) Online Resource